Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.
about
Fibroblast growth factor signaling in skeletal development and diseaseSignaling mechanisms implicated in cranial sutures pathophysiology: CraniosynostosisAnabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.Mechanical stimulation orchestrates the osteogenic differentiation of human bone marrow stromal cells by regulating HDAC1Loss of Rictor with aging in osteoblasts promotes age-related bone loss.miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2.The Lyme Disease Pathogen Borrelia burgdorferi Infects Murine Bone and Induces Trabecular Bone Loss.Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osCellular and molecular mechanisms of alcohol-induced osteopenia.Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis.Osteoblast as a target of anti-osteoporotic treatment.TIMP-1 suppressed by miR-138 participates in endoplasmic reticulum stress-induced osteoblast apoptosis in osteoporosis.Insights into the roles of lncRNAs in skeletal and dental diseases.The Expanding Life and Functions of Osteogenic Cells: From Simple Bone-Making Cells to Multifunctional Cells and Beyond.Cell-based RNAi screening and high-content analysis in primary calvarian osteoblasts applied to identification of osteoblast differentiation regulators
P2860
Q26798215-26845062-6A74-4DCE-B588-5A4BCA1C47B9Q28073737-3A3CF625-9FF9-45D2-987F-754B193F6528Q36727361-C80E7A23-C585-4A70-87C1-C701EEEBF80EQ37030280-FE0E5789-F529-4C03-9CDA-6BF1E3690D29Q37465826-DC520338-903C-405E-9F55-5BBCF9156169Q37465938-DE543626-2447-499E-973A-4BAFC335319FQ37611994-BF51CEDF-A80F-49D1-87EC-C198DBB20D03Q37643521-52622211-D3E9-4459-8D26-1347F58799C3Q39412927-3C45E57A-9A97-4D0C-9E3A-607F0BA65C35Q47559348-DA6C2149-E337-4475-A094-8B4E806ADD77Q47996918-9EC966BD-0063-4D63-B06E-11DF7EB0E2A9Q49372075-E6A5AA8F-010A-4B89-88BF-F8BB89CE1B1BQ50022072-8406D360-8533-4B60-B002-69FDA75168D9Q50069952-5398B395-B7CA-44AA-8B70-BA56DE949D28Q58719766-D9359BDD-F6AA-45C1-B8D8-2124E62418B3
P2860
Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Osteoblast dysfunctions in bon ...... sms to therapeutic strategies.
@en
type
label
Osteoblast dysfunctions in bon ...... sms to therapeutic strategies.
@en
prefLabel
Osteoblast dysfunctions in bon ...... sms to therapeutic strategies.
@en
P2860
P1476
Osteoblast dysfunctions in bon ...... sms to therapeutic strategies.
@en
P2093
Pierre J Marie
P2860
P2888
P304
P356
10.1007/S00018-014-1801-2
P577
2014-12-09T00:00:00Z